Filing Details

Accession Number:
0001415889-24-011482
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-24 18:54:25
Reporting Period:
2024-04-22
Accepted Time:
2024-04-24 18:54:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1855644 Zura Bio Ltd ZURA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1970231 Michael Howell C/O 4225 Executive Square, Suite 600
La Jolla CA 92037
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Shares Acquisiton 2024-04-22 7,987 $3.13 7,987 No 4 P Indirect By corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By corporation
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Ordinary Shares 114,395 Direct
Footnotes
  1. These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Mountaineer Biosciences, Inc. ("Mountaineer") at a purchase price of $3.13 per share.
  2. These shares are beneficially owned by Mountaineer. The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.